Cytomegalovirus retinitis: a rare but preventable cause of blindness in dermatology patients

J Cutan Med Surg. 2014 Jul-Aug;18(4):287-90. doi: 10.2310/7750.2013.13149.

Abstract

Importance: Dermatologists are using an increasing range of immunomodulatory therapies to treat an expanding number of skin diseases. Complications of therapy are broad and include infection. Cytomegalovirus (CMV) retinitis has not been reported in association with dermatologic disease.

Observations: We report two cases of CMV retinitis associated with immunosuppression for eczema and pemphigus vulgaris. In both cases, patients were receiving corticosteroid and a second-line immunosuppressive agent (cyclosporine or mycophenolate mofetil). Disease presented in both patients with painless visual loss.

Conclusions and relevance: Patients receiving immunosuppressive therapy should be monitored for blurred vision, floaters, or visual loss and referred for urgent assessment to ensure accurate diagnosis and prompt treatment of possible CMV retinitis.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Aged, 80 and over
  • Blindness / etiology*
  • Cyclosporine / adverse effects
  • Cytomegalovirus Retinitis / etiology*
  • Eczema / drug therapy
  • Glucocorticoids / adverse effects
  • Humans
  • Immunosuppression Therapy / adverse effects*
  • Immunosuppressive Agents / adverse effects*
  • Male
  • Mycophenolic Acid / adverse effects
  • Mycophenolic Acid / analogs & derivatives
  • Pemphigus / drug therapy
  • Prednisolone / adverse effects
  • Rare Diseases / virology*

Substances

  • Glucocorticoids
  • Immunosuppressive Agents
  • Cyclosporine
  • Prednisolone
  • Mycophenolic Acid